Report copyright - Annexin-A1: A New Immunomodulation / Checkpoint …...CellProliferation:ApanelofcancercelllinesweretreatedwithMDX-124,acommercial anti-ANXA1antibodyorIgGisotypecontrol(0-10μM)for72hours.Cellviabilitywas
Please pass captcha verification before submit form